21-hydroxylase deficiency overview: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
'''Congenital adrenal hyperplasia due to [[21-hydroxylase]] deficiency''' ('''21-OH CAH'''), in all its forms, accounts for about 95% of diagnosed cases of [[congenital adrenal hyperplasia]], and '''CAH''' in most contexts refers to 21-hydroxylase deficiency. | '''Congenital adrenal hyperplasia due to [[21-hydroxylase]] deficiency''' ('''21-OH CAH'''), in all its forms, accounts for about 95% of diagnosed cases of [[congenital adrenal hyperplasia]], and '''CAH''' in most contexts refers to 21-hydroxylase deficiency. | ||
==Historical Perspective== | |||
Congenital adrenal hyperplasia was first discovered by Luigi De Crecchio, an Italian anatomist. | |||
== Pathophysiology == | |||
Development of congenital adrenal hyperplasia is the result of multiple enzymatic deficiencies. | |||
==Causes== | |||
In general congenital adrenal hyperplasia may be caused by either 21-hydroxylase deficiency, 11-β hydroxylase deficiency or 17-α hydroxylase deficiency. | |||
==Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases== | |||
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency must be differentiated from other causes of adrenal hyperplasia such as 11-β hydroxylase deficiency and 17-α hydroxylase deficiency. | |||
==Epidemiology and Demographics== | |||
The incidence of 21-hydroxlase deficient congenital adrenal hyperplasia is approximately 1 per 15,000 birth. | |||
==Risk Factors== | |||
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is [[Mutation]]s in the '''CYP21A2''' gene. | |||
==Screening== | |||
==Natural History== | |||
The prognosis of 21-hydroxylase deficient congenital adrenal hyperplasia is generally good with treatment. Common complications of 21-hydroxylase deficient congenital adrenal hyperplasia include [[Adrenal crisis]], [[Infertility]], and [[precocious puberty]]. | |||
==History and Symptoms== | |||
Symptoms of 21-hydroxylase deficient congenital adrenal hyperplasia include [[dehydration]], [[vomiting]] and [[weight loss]], symptoms occur later may include [[virilization]] and [[infertility]] | |||
==Physical Examination== | |||
Patients with 21-hydroxylase deficient congenital adrenal hyperplasia usually appear [[underweight]] and [[dehydrated]]. Physical examination of patients with 21-hydroxylase deficient congenital adrenal hyperplasia is usually remarkable for [[hypotension]] and [[virilization]]. | |||
==References== | ==References== | ||
Revision as of 20:32, 4 September 2015
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency overview On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency overview |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OH CAH), in all its forms, accounts for about 95% of diagnosed cases of congenital adrenal hyperplasia, and CAH in most contexts refers to 21-hydroxylase deficiency.
Historical Perspective
Congenital adrenal hyperplasia was first discovered by Luigi De Crecchio, an Italian anatomist.
Pathophysiology
Development of congenital adrenal hyperplasia is the result of multiple enzymatic deficiencies.
Causes
In general congenital adrenal hyperplasia may be caused by either 21-hydroxylase deficiency, 11-β hydroxylase deficiency or 17-α hydroxylase deficiency.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency must be differentiated from other causes of adrenal hyperplasia such as 11-β hydroxylase deficiency and 17-α hydroxylase deficiency.
Epidemiology and Demographics
The incidence of 21-hydroxlase deficient congenital adrenal hyperplasia is approximately 1 per 15,000 birth.
Risk Factors
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is Mutations in the CYP21A2 gene.
Screening
Natural History
The prognosis of 21-hydroxylase deficient congenital adrenal hyperplasia is generally good with treatment. Common complications of 21-hydroxylase deficient congenital adrenal hyperplasia include Adrenal crisis, Infertility, and precocious puberty.
History and Symptoms
Symptoms of 21-hydroxylase deficient congenital adrenal hyperplasia include dehydration, vomiting and weight loss, symptoms occur later may include virilization and infertility
Physical Examination
Patients with 21-hydroxylase deficient congenital adrenal hyperplasia usually appear underweight and dehydrated. Physical examination of patients with 21-hydroxylase deficient congenital adrenal hyperplasia is usually remarkable for hypotension and virilization.